nodes	percent_of_prediction	percent_of_DWPC	metapath
Clevidipine—CYP1A2—Pentoxifylline—systemic scleroderma	0.184	0.222	CbGbCtD
Clevidipine—CYP1A2—Leflunomide—systemic scleroderma	0.176	0.212	CbGbCtD
Clevidipine—CYP2C9—Leflunomide—systemic scleroderma	0.158	0.191	CbGbCtD
Clevidipine—CYP2D6—Captopril—systemic scleroderma	0.114	0.137	CbGbCtD
Clevidipine—CYP2C19—Prednisone—systemic scleroderma	0.0941	0.114	CbGbCtD
Clevidipine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0569	0.0687	CbGbCtD
Clevidipine—CYP3A4—Prednisone—systemic scleroderma	0.0455	0.0549	CbGbCtD
Clevidipine—CYP2C9—cardial valve—systemic scleroderma	0.0244	0.448	CbGeAlD
Clevidipine—Ileus—Mycophenolic acid—systemic scleroderma	0.00596	0.0508	CcSEcCtD
Clevidipine—Ileus—Mycophenolate mofetil—systemic scleroderma	0.0047	0.0401	CcSEcCtD
Clevidipine—CACNA1S—tendon—systemic scleroderma	0.00429	0.0786	CbGeAlD
Clevidipine—Renal failure acute—Captopril—systemic scleroderma	0.00422	0.036	CcSEcCtD
Clevidipine—Blood triglycerides increased—Prednisone—systemic scleroderma	0.00344	0.0294	CcSEcCtD
Clevidipine—Renal failure acute—Mycophenolic acid—systemic scleroderma	0.00331	0.0283	CcSEcCtD
Clevidipine—Atrial fibrillation—Mycophenolic acid—systemic scleroderma	0.00323	0.0276	CcSEcCtD
Clevidipine—CACNA1C—connective tissue—systemic scleroderma	0.00303	0.0554	CbGeAlD
Clevidipine—Renal failure acute—Lisinopril—systemic scleroderma	0.00299	0.0255	CcSEcCtD
Clevidipine—Atrial fibrillation—Lisinopril—systemic scleroderma	0.00291	0.0248	CcSEcCtD
Clevidipine—CACNA1C—smooth muscle tissue—systemic scleroderma	0.00277	0.0507	CbGeAlD
Clevidipine—Renal failure acute—Mycophenolate mofetil—systemic scleroderma	0.00262	0.0223	CcSEcCtD
Clevidipine—Atrial fibrillation—Mycophenolate mofetil—systemic scleroderma	0.00255	0.0217	CcSEcCtD
Clevidipine—Tachycardia—Pentoxifylline—systemic scleroderma	0.00246	0.021	CcSEcCtD
Clevidipine—Hypotension—Pentoxifylline—systemic scleroderma	0.00236	0.0201	CcSEcCtD
Clevidipine—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00225	0.0192	CcSEcCtD
Clevidipine—CACNA1C—digestive system—systemic scleroderma	0.00218	0.04	CbGeAlD
Clevidipine—Acute coronary syndrome—Lisinopril—systemic scleroderma	0.00209	0.0179	CcSEcCtD
Clevidipine—Myocardial infarction—Lisinopril—systemic scleroderma	0.00208	0.0178	CcSEcCtD
Clevidipine—CACNA1D—lung—systemic scleroderma	0.00198	0.0362	CbGeAlD
Clevidipine—Dyspnoea—Mometasone—systemic scleroderma	0.00194	0.0166	CcSEcCtD
Clevidipine—Tachycardia—Captopril—systemic scleroderma	0.00187	0.0159	CcSEcCtD
Clevidipine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00186	0.0159	CcSEcCtD
Clevidipine—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	0.00183	0.0157	CcSEcCtD
Clevidipine—CACNA1C—lung—systemic scleroderma	0.00182	0.0334	CbGeAlD
Clevidipine—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	0.00182	0.0156	CcSEcCtD
Clevidipine—Hypotension—Captopril—systemic scleroderma	0.00179	0.0153	CcSEcCtD
Clevidipine—Dyspnoea—Captopril—systemic scleroderma	0.00171	0.0146	CcSEcCtD
Clevidipine—Vomiting—Pentoxifylline—systemic scleroderma	0.0016	0.0137	CcSEcCtD
Clevidipine—Headache—Pentoxifylline—systemic scleroderma	0.00158	0.0135	CcSEcCtD
Clevidipine—Hypotension—Azathioprine—systemic scleroderma	0.00156	0.0133	CcSEcCtD
Clevidipine—Tachycardia—Leflunomide—systemic scleroderma	0.00154	0.0131	CcSEcCtD
Clevidipine—BCHE—smooth muscle tissue—systemic scleroderma	0.00152	0.0278	CbGeAlD
Clevidipine—Nausea—Pentoxifylline—systemic scleroderma	0.0015	0.0128	CcSEcCtD
Clevidipine—BCHE—skin of body—systemic scleroderma	0.0015	0.0274	CbGeAlD
Clevidipine—Renal failure acute—Methotrexate—systemic scleroderma	0.00148	0.0126	CcSEcCtD
Clevidipine—Hypotension—Leflunomide—systemic scleroderma	0.00147	0.0126	CcSEcCtD
Clevidipine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00147	0.0125	CcSEcCtD
Clevidipine—Dyspnoea—Leflunomide—systemic scleroderma	0.00141	0.012	CcSEcCtD
Clevidipine—Hypotension—Mycophenolic acid—systemic scleroderma	0.00141	0.012	CcSEcCtD
Clevidipine—Vomiting—Mometasone—systemic scleroderma	0.00138	0.0118	CcSEcCtD
Clevidipine—CYP2C19—digestive system—systemic scleroderma	0.00136	0.025	CbGeAlD
Clevidipine—Headache—Mometasone—systemic scleroderma	0.00136	0.0116	CcSEcCtD
Clevidipine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00134	0.0114	CcSEcCtD
Clevidipine—Tachycardia—Lisinopril—systemic scleroderma	0.00132	0.0113	CcSEcCtD
Clevidipine—Nausea—Mometasone—systemic scleroderma	0.00129	0.011	CcSEcCtD
Clevidipine—Hypotension—Lisinopril—systemic scleroderma	0.00127	0.0108	CcSEcCtD
Clevidipine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.00124	0.0106	CcSEcCtD
Clevidipine—Myocardial infarction—Prednisone—systemic scleroderma	0.00124	0.0106	CcSEcCtD
Clevidipine—Hypersensitivity—Azathioprine—systemic scleroderma	0.00123	0.0105	CcSEcCtD
Clevidipine—Vomiting—Captopril—systemic scleroderma	0.00122	0.0104	CcSEcCtD
Clevidipine—Dyspnoea—Lisinopril—systemic scleroderma	0.00121	0.0103	CcSEcCtD
Clevidipine—Headache—Captopril—systemic scleroderma	0.0012	0.0102	CcSEcCtD
Clevidipine—BCHE—digestive system—systemic scleroderma	0.0012	0.022	CbGeAlD
Clevidipine—Hypersensitivity—Leflunomide—systemic scleroderma	0.00116	0.00991	CcSEcCtD
Clevidipine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00989	CcSEcCtD
Clevidipine—Nausea—Captopril—systemic scleroderma	0.00114	0.0097	CcSEcCtD
Clevidipine—CYP1A2—digestive system—systemic scleroderma	0.00111	0.0204	CbGeAlD
Clevidipine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00947	CcSEcCtD
Clevidipine—Vomiting—Azathioprine—systemic scleroderma	0.00106	0.00906	CcSEcCtD
Clevidipine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00903	CcSEcCtD
Clevidipine—CYP2C9—digestive system—systemic scleroderma	0.00106	0.0194	CbGeAlD
Clevidipine—Headache—Azathioprine—systemic scleroderma	0.00105	0.00893	CcSEcCtD
Clevidipine—CYP2E1—digestive system—systemic scleroderma	0.001	0.0184	CbGeAlD
Clevidipine—Vomiting—Leflunomide—systemic scleroderma	0.001	0.00856	CcSEcCtD
Clevidipine—BCHE—lung—systemic scleroderma	0.001	0.0183	CbGeAlD
Clevidipine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000998	0.00852	CcSEcCtD
Clevidipine—Nausea—Azathioprine—systemic scleroderma	0.000992	0.00846	CcSEcCtD
Clevidipine—Headache—Leflunomide—systemic scleroderma	0.000988	0.00843	CcSEcCtD
Clevidipine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000956	0.00816	CcSEcCtD
Clevidipine—CYP2E1—tendon—systemic scleroderma	0.000954	0.0175	CbGeAlD
Clevidipine—Headache—Mycophenolic acid—systemic scleroderma	0.000942	0.00804	CcSEcCtD
Clevidipine—Nausea—Leflunomide—systemic scleroderma	0.000936	0.00799	CcSEcCtD
Clevidipine—CYP1A2—lung—systemic scleroderma	0.000931	0.0171	CbGeAlD
Clevidipine—Nausea—Mycophenolic acid—systemic scleroderma	0.000893	0.00762	CcSEcCtD
Clevidipine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000875	0.00746	CcSEcCtD
Clevidipine—Vomiting—Lisinopril—systemic scleroderma	0.000861	0.00735	CcSEcCtD
Clevidipine—Headache—Lisinopril—systemic scleroderma	0.000849	0.00724	CcSEcCtD
Clevidipine—CYP2E1—lung—systemic scleroderma	0.000837	0.0153	CbGeAlD
Clevidipine—CYP3A4—digestive system—systemic scleroderma	0.000807	0.0148	CbGeAlD
Clevidipine—Nausea—Lisinopril—systemic scleroderma	0.000805	0.00687	CcSEcCtD
Clevidipine—CYP2D6—digestive system—systemic scleroderma	0.000794	0.0145	CbGeAlD
Clevidipine—Tachycardia—Prednisone—systemic scleroderma	0.000785	0.0067	CcSEcCtD
Clevidipine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000755	0.00644	CcSEcCtD
Clevidipine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000744	0.00635	CcSEcCtD
Clevidipine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000705	0.00602	CcSEcCtD
Clevidipine—Hypotension—Methotrexate—systemic scleroderma	0.000628	0.00536	CcSEcCtD
Clevidipine—Dyspnoea—Methotrexate—systemic scleroderma	0.000599	0.00512	CcSEcCtD
Clevidipine—Hypersensitivity—Prednisone—systemic scleroderma	0.000593	0.00506	CcSEcCtD
Clevidipine—Vomiting—Prednisone—systemic scleroderma	0.000512	0.00437	CcSEcCtD
Clevidipine—Headache—Prednisone—systemic scleroderma	0.000504	0.0043	CcSEcCtD
Clevidipine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000495	0.00423	CcSEcCtD
Clevidipine—Nausea—Prednisone—systemic scleroderma	0.000478	0.00408	CcSEcCtD
Clevidipine—Vomiting—Methotrexate—systemic scleroderma	0.000428	0.00365	CcSEcCtD
Clevidipine—Headache—Methotrexate—systemic scleroderma	0.000421	0.0036	CcSEcCtD
Clevidipine—Nausea—Methotrexate—systemic scleroderma	0.000399	0.00341	CcSEcCtD
